Burzynski, Stanislaw R <br/><br/>
The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.  [electronic resource] 

 -  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery  Dec 2014 
 - 2051-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1433-0350 
<br/><br/><label>Standard No.: </label>10.1007/s00381-014-2401-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Benzeneacetamides--adverse effects<br/>Brain Stem Neoplasms--drug therapy<br/>Child<br/>Child, Preschool<br/>Disease Progression<br/>Drug Combinations<br/>Female<br/>Glioma--drug therapy<br/>Glutamine--adverse effects<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Neoplasm Recurrence, Local--drug therapy<br/>Phenylacetates--adverse effects<br/>Piperidones--adverse effects<br/>Pons<br/>Survival Rate